It teased the positive results in July. Along with Beyfortus (nirsevimab), it is also a potential rival to Pfizer's RSV vaccine Abrysvo, which can be given to women during pregnancy to protect ...
Children’s Hospital of Erlanger is now accepting appointments to receive the Beyfortus respiratory syncytial virus (RSV) vaccine through Children’s General Pediatrics located at the Kennedy ...
Nirsevimab (Beyfortus), an antibody targeting respiratory syncytial virus (RSV), is indicated for newborns and infants to prevent bronchiolitis. Available since September 2023, its widespread use ...
AstraZeneca and Sanofi have secured approval in the EU for Beyfortus, the first single-dose drug to protect newborns and infants from respiratory syncytial virus (RSV) infections. The antibody ...
Vaccine skepticism concerns impact biotech investor sentiment Shares of European drug makers fall, along with U.S. companies Analysts worry about RFK Jr.'s influence on HHS agencies Nov 15 ...
Subscription boxes land in a good-gift sweet spot of being thoughtful without requiring too much effort. All you have to do is select the one that best matches your recipient’s interests ...
MediciNova (MNOV) was notified by Sanofi (SNY) that the Sanofi/Novartis (NVS) litigation was settled. Accordingly, MediciNova is entitled to receive a certain amount of monetary damages through ...
"Whether it’s toys, books or other thoughtful presents, each donation brings comfort to patients and their families," officials said. According to Hailey Thompson, certified child life ...
* Further details of differences between Reported and Core are shown in Table 12 ...
Funding to support clinical proof-of-concept for the lead program, VIPER-101 PHILADELPHIA, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Vittoria Biotherapeutics, Inc., a clinical-stage immunotherapy company ...
The preventive monoclonal antibody nirsevimab (Beyfortus) was 89% effective against infant hospitalization in Alaska for respiratory syncytial virus (RSV) in their first RSV season and 76% and 88% ...